Axon Enterprise, Inc $AXON Shares Bought by Atala Financial Inc

Atala Financial Inc raised its position in Axon Enterprise, Inc (NASDAQ:AXON) by 105.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,520 shares of the biotechnology company’s stock after purchasing an additional 1,293 shares during the quarter. Atala Financial Inc’s holdings in Axon Enterprise were worth $1,808,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Stone House Investment Management LLC purchased a new position in Axon Enterprise in the third quarter valued at approximately $29,000. Hemington Wealth Management grew its stake in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after buying an additional 17 shares during the period. Whipplewood Advisors LLC increased its position in shares of Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after acquiring an additional 27 shares in the last quarter. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise in the third quarter worth $34,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise in the 2nd quarter valued at $37,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Barclays decreased their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. The Goldman Sachs Group decreased their target price on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Wall Street Zen lowered Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Royal Bank Of Canada initiated coverage on Axon Enterprise in a report on Monday, November 17th. They set an “outperform” rating and a $860.00 target price on the stock. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $805.71.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,134 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the transaction, the chief accounting officer directly owned 13,740 shares of the company’s stock, valued at $8,244,000. This represents a 7.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jeri Williams sold 100 shares of the stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $550.63, for a total value of $55,063.00. Following the transaction, the director owned 1,316 shares of the company’s stock, valued at approximately $724,629.08. This trade represents a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 60,540 shares of company stock worth $34,684,738 over the last ninety days. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $451.29 on Wednesday. The firm has a 50-day moving average of $575.49 and a two-hundred day moving average of $664.42. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. The stock has a market cap of $35.61 billion, a P/E ratio of 142.81, a PEG ratio of 13.86 and a beta of 1.48. Axon Enterprise, Inc has a 1-year low of $434.62 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). The business had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The company’s revenue was up 30.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.45 EPS. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.